Mois : mai 2017

About the position A postdoctoral position is available for our activities on biomedical technologies at the Research Laboratory of IBM in Zurich. These activities aim at applying IBM’s expertise in microtechnology and microfluidics towards the development of next generation bioanalytical tools in the context of personalized tumor profiling. This multidisciplinary research is problem-oriented and is pursued in collaboration with a world leading partner on tumor profiling. In this position, research will focus on applying IBM’s microfluidic probe (MFP) technology to profiling tumors locally. MFP is a non-contact, scanning microfluidic device that can pattern surfaces with proteins in an additive and subtractive manner, form gradients of proteins on surfaces and interacts with cells and tissue sections. Part of this work is within the framework of a European Union project (BioProbe, www.bioprobe.eu).

More information : Post-doc – IBM Zurich – 2017

These cells are (i) the causative agents of late relapse, (ii) refractory to treatments and (iii) leading to relapsing patients poor survival. Deep sequencing by NGS allows identification of these residual cells but their detection is still technically challenging due to lack of phenotypic markers. There is a critical need to find new ways to detect and purify them to anticipate relapse.

More information : PhD_topics_SMMiL-E